Nicholas Investment Partners, LP Kal Vista Pharmaceuticals, Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$10.35 - $12.49 $17,739 - $21,407	1,714 Added 0.94%	184,358 $2.17 Million
Q1 2024 May 13, 2024	BUY	$11.07 - $16.04 $2.02 Million - $2.93 Million	182,644 New	182,644 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $2.69 Million - $3.97 Million	-217,389 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $7.42 Million - $10.6 Million	-433,514 Reduced 66.6%	217,389 $3.79 Million
Q2 2021 Aug 10, 2021	BUY	$23.12 - $29.91 $1.31 Million - $1.7 Million	56,773 Added 9.56%	650,903 $15.6 Million
Q1 2021 May 14, 2021	BUY	$14.69 - $42.57 $8.73 Million - $25.3 Million	594,130 New	594,130 $15.3 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.